These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2769329)

  • 21. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
    Miettinen M; Franssila KO; Saxén E
    Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
    Kamel OW; Gelb AB; Shibuya RB; Warnke RA
    Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Proliferating cells in Hodgkin's disease].
    Schmid C; Isaacson PG
    Verh Dtsch Ges Pathol; 1992; 76():151-4. PubMed ID: 1283248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A quantitative study of mast cells in Hodgkin's disease.
    Crocker J; Smith PJ
    J Clin Pathol; 1984 May; 37(5):519-22. PubMed ID: 6725599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hodgkin's disease -- analysis of fifty-three autopsy cases.
    Aozasa K; Ito H; Bandai H; Yamamoto S
    Acta Pathol Jpn; 1981 Jul; 31(4):663-73. PubMed ID: 7282365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.
    Kadin ME; Agnarsson BA; Ellingsworth LR; Newcom SR
    Am J Pathol; 1990 Jun; 136(6):1209-14. PubMed ID: 2356855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotypic study of lymphocyte predominance Hodgkin's disease.
    Bishop PW; Harris M; Smith AP; Elsam KJ
    Histopathology; 1991 Jan; 18(1):19-24. PubMed ID: 2013458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated.
    Taylor GM; Gokhale DA; Crowther D; Woll P; Harris M; Alexander F; Jarrett R; Cartwright RA
    Leukemia; 1996 May; 10(5):854-9. PubMed ID: 8656683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico.
    Quintanilla-Martínez L; Gamboa-Domńquez A; Gamez-Ledesma I; Angeles-Angeles A; Mohar A
    Mod Pathol; 1995 Aug; 8(6):675-9. PubMed ID: 8532705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte predominance Hodgkin's disease: a reappraisal based upon histological and immunophenotypical findings in relapsing cases.
    Regula DP; Weiss LM; Warnke RA; Dorfman RF
    Histopathology; 1987 Nov; 11(11):1107-20. PubMed ID: 3692445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease.
    Tefferi A; Zellers RA; Banks PM; Therneau TM; Colgan JP
    J Clin Oncol; 1990 Dec; 8(12):1959-65. PubMed ID: 2230888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy results for nodular sclerosing Hodgkin's disease after clinical staging.
    Johnson RE; Zimbler H; Berard CW; Herdt J; Brereton HD
    Cancer; 1977 Apr; 39(4):1439-44. PubMed ID: 856440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
    Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
    Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The histology of the initial relapse of Hodgkin's disease.
    Colby TV; Warnke RA
    Cancer; 1980 Jan; 45(2):289-92. PubMed ID: 7351011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphocyte predominant Hodgkin's disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes.
    Crennan E; D'Costa I; Liew KH; Thompson J; Laidlaw C; Cooper I; Quong G
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):333-7. PubMed ID: 7530700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of Hodgkin's disease at diagnosis in young children.
    White L; McCourt BA; Isaacs H; Siegel SE; Stowe SM; Higgins GR
    Am J Pediatr Hematol Oncol; 1983; 5(3):251-7. PubMed ID: 6625107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.